Month: June 2020

SÃO PAULO, Brazil, June 19, 2020 (GLOBE NEWSWIRE) — XP Inc. (Nasdaq: XP), a leading, technology-driven financial services platform and a trusted provider of low-fee financial products and services in Brazil, announced the creation of an ESG (Environmental, Social and Governance) board and initiatives to provide the best products, services, content and recommendations focused on ESG, in addition to further leveraging the company’s internal standards and practices. The Company seeks to lead ESG initiatives in the Brazilian financial markets, democratizing access to content and quality products to customers.This is a natural move, recognizing the importance of the theme ESG in the world, and its potential benefits for Brazil specifically. According to Bruno Constantino, XP Inc.’s CFO, “XP understands its responsibility in our...

YARDLEY, Pa., June 19, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the Company has been named one of the Philadelphia Business Journal’s “Best Places to Work” for 2020 in the medium-sized company category for the third year in a row.“We are extremely proud of the culture we have built at Optinose over the last ten years. Even during these extraordinary times, maintaining a fun and productive work environment in which people can come together and accomplish great things continues to be our highest priority,” said Peter Miller, CEO of Optinose. “We are excited to be recognized once again as a ‘Best Place to Work’ by the Philadelphia Business Journal. Our goal is that each colleague feels a deep connection...

ALMONTE, Ontario, June 19, 2020 (GLOBE NEWSWIRE) — 3 Sixty Risk Solutions Ltd. (“3 Sixty” or the “Company”) (CSE: SAFE) (OTCQB: SAYFF) (FSE: 62P2) announces that its application for a management cease trade order (“MCTO”) under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”) has been approved by the Ontario Securities Commission (“OSC”) and an MCTO has been issued. The MCTO does not affect the ability of investors who are not insiders to trade in the securities of the Company.The Company will finalize and file the following continuous disclosure documents (collectively the “Documents”) on or before 15 July 2020:The Company’s Annual Audited Financial Statements for the financial year ended December 31, 2019.The Company’s Management Discussion & Analysis for the financial year ended December 31, 2019.Until...

HASBROUCK HEIGHTS, N.J., June 19, 2020 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is very pleased to report that key steps in its regulatory submission preparations have been completed and the project is firmly on-track. The majority of its regulatory documentation has proceeded very well, despite the inherent limitations of the business environment in 2020. Certain tasks have been hampered by the Covid pandemic restrictions, similar to other companies in the sector. These remaining tasks are expected to be completed reasonably soon as the Company regains the ability to retrieve required documentation from external sites and to complete other required tasks and on-site activities that were hindered due to the global restrictions in place.Dr. Paul Averback, CEO commented “We are extremely pleased with...

SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced the pricing of its initial public offering of 6,666,667 shares of common stock at a public offering price of $15.00 per share. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Progenity, are expected to be $100 million. All of the shares are being offered by Progenity. The shares are expected to begin trading on The Nasdaq Global Market on June 19, 2020 under the ticker symbol “PROG.”  In addition, Progenity has granted the underwriters a 30-day option to purchase up to an additional 1,000,000 shares of common stock at the initial...

TORONTO, June 19, 2020 (GLOBE NEWSWIRE) — DREAM HARD ASSET ALTERNATIVES TRUST (TSX: DRA.UN) (“Dream Alternatives” or the “Trust”) today announced its June 2020 monthly distribution in the amount of 3.333 cents per Unit (40 cents annualized). The June distribution will be payable on July 15, 2020 to unitholders of record as at June 30, 2020.Dream Alternatives provides investors with access to an exceptional portfolio of real estate development opportunities and alternative assets that would not be otherwise available in a public and fully transparent vehicle, managed by an experienced team with a successful track record in these areas. The objectives of the Trust are to provide investors with a portfolio of high-quality real estate development opportunities and alternative assets, concentrated in core geographic markets; balance...

TORONTO, June 19, 2020 (GLOBE NEWSWIRE) — DREAM OFFICE REIT (TSX: D.UN) (“Dream Office” or the “Trust”) today announced its June 2020 monthly distribution of 8.333 cents per REIT Unit, Series A ($1.00 annualized). The June distribution will be payable on July 15, 2020 to unitholders of record as at June 30, 2020.Dream Office REIT is an unincorporated, open-ended real estate investment trust. Dream Office REIT owns well-located, high-quality central business district office properties in major urban centres across Canada, with a focus on downtown Toronto. For more information, please visit our website at www.dreamofficereit.ca.For further information, please contact:

TORONTO, June 19, 2020 (GLOBE NEWSWIRE) — DREAM INDUSTRIAL REIT (TSX: DIR.UN) today announced its June 2020 monthly distribution in the amount of 5.833 cents per Unit (70 cents annualized). The June distribution will be payable on July 15, 2020 to unitholders of record as at June 30, 2020.Dream Industrial REIT is an unincorporated, open-ended real estate investment trust. As at March 31, 2020, Dream Industrial REIT owns and operates a portfolio of 262 industrial properties comprising approximately 25.8 million square feet of gross leasable area in key markets across North America and a growing presence in strong European industrial markets. Its objective is to continue to grow and upgrade the quality of its portfolio and to provide attractive overall returns to its unitholders. For more information, please visit www.dreamindustrialreit.ca.For...

TOM’S RIVER, N.J., June 19, 2020 (GLOBE NEWSWIRE) — Quad M Solutions, Inc. and Otegrity Inc. have signed a Master Broker Agreement.Otegrity is a back-office solutions company that provides accounting, finance, insurance, payroll, Human Resources and staffing solutions to clients throughout the United States with a regional focus on the southeast, U.S. Otegrity Inc. provides unique solutions to the real estate broker, healthcare, and information technology industries, which are dominated by independent contractors and GIG economy workers. This is Quad M Solution’s ideal target market. Otegrity is a Managing General Agency (MGA) that has built a sales network that has access to 5 million employees and approximately 100,000 businesses. The Company has recently contracted with sales agencies/agents that sell various health indemnity...

MIAMI, June 19, 2020 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer, announced that it has enrolled the first patient in its Phase 2 clinical trial of VERU-111, a novel microtubule depolymerization drug to combat COVID-19, the global pandemic disease caused by the coronavirus SARS-CoV-2.“It’s clear that new and more effective drugs are still needed to fight the COVID-19 pandemic. We are excited to lead the effort to evaluate a novel drug like VERU-111. VERU-111 has the potential for both antiviral and anti-inflammatory treatment of patients infected with SARS-CoV-2 who are at high risk for Acute Respiratory Distress Syndrome,” said Michael S. Gordon, MD, Medical Director, HonorHeatlh Research Institute...